Fabio
7.1 KiB
7.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relating to the price of prescription drugs. | Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for <i>prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or</i>]<b> nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by prescription drug manufacturers, drugs reported by insurers in filings and insulin drugs marketed in this state, that</b> are expected to create affordability challenges for health systems <i>and</i>]<b> or high out-of-pocket costs for</b> patients in Oregon <i>or health inequities for communities of color</i>]<b> based on specified criteria</b>. Requires <b>department, in consultation with</b> board<b>,</b> to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. | us/states/or | Oregon Legislative Assembly | 2021 Regular Session | SB 844 | Oregon SB 844 (2021 Regular Session) |
|
enacted |
|
8 | 26 | 4 | 2021-03-10T18:54:55+00:00 | 2021-08-20T17:10:35+00:00 | openstates | ocd-bill/6e3ddba7-3757-4f3e-8247-b595adcf0a2e | https://olis.oregonlegislature.gov/liz/2021R1/Measures/Overview/SB844 | 624cc0a92a2937fc89dd5e1ef11586d54e04db50e094461963ac9b95e6b93ea7 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Oregon SB 844 (2021 Regular Session) — Relating to the price of prescription drugs.
Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or] nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by prescription drug manufacturers, drugs reported by insurers in filings and insulin drugs marketed in this state, that are expected to create affordability challenges for health systems and] or high out-of-pocket costs for patients in Oregon or health inequities for communities of color] based on specified criteria. Requires department, in consultation with board, to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Senate Amendments to Introduced (filed) — source
- A-Engrossed (committee substitute) — source
- B-Engrossed (committee substitute) — source
- JWM Amendment -A9 (committee substitute) — source
- SHC Amendment -1 (committee substitute) — source
- Senate Amendments to A-Engrossed (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Rules suspended. Third reading. Carried by Patterson. Passed. — 17–11 (pass) · upper
- Heard and Reported Out with Amendments — 3–2 (pass) · upper
- Heard and Reported Out with Amendments — 30–14 (pass) · legislature
- Rules suspended. Third reading. Carried by Prusak. Passed. — 36–20 (pass) · lower
Sponsors
- Deb Patterson — primary (person)
- Rachel Prusak — primary (person)
- James Manning Jr. — cosponsor (person)
- Sheri Schouten — cosponsor (person)
- Wlnsvey Campos — cosponsor (person)
- Zach Hudson — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-03-10T18:54:55+00:00 Introduction and first reading. Referred to President's desk.
introduction, reading-1, referral-committee - 2021-03-10T23:52:38+00:00 Referred to Health Care.
referral-committee - 2021-03-22T20:01:00+00:00 Public Hearing held.
- 2021-03-24T20:01:00+00:00 Public Hearing held.
- 2021-04-05T20:01:00+00:00 Work Session held.
- 2021-04-07T20:02:00+00:00 Work Session held.
- 2021-04-16T18:08:16+00:00 Recommendation: Do pass with amendments and be referred to Ways and Means. (Printed A-Eng.)
committee-passage-favorable - 2021-04-16T18:08:17+00:00 Referred to Ways and Means by order of the President.
referral-committee - 2021-06-14T19:40:00+00:00 Assigned to Subcommittee On Human Services.
referral-committee - 2021-06-16T15:03:00+00:00 Returned to Full Committee.
- 2021-06-16T15:02:00+00:00 Work Session held.
- 2021-06-21T21:02:00+00:00 Work Session held.
- 2021-06-23T18:52:28+00:00 Recommendation: Do pass with amendments to the A-Eng. bill. (Printed B-Eng.)
committee-passage-favorable - 2021-06-24T18:12:30+00:00 Second reading.
reading-2 - 2021-06-24T20:35:35+00:00 Rules suspended. Third reading. Carried by Patterson. Passed.
passage, reading-3 - 2021-06-24T22:18:47+00:00 Rules suspended. First reading. Referred to Speaker's desk.
introduction, reading-1, referral-committee - 2021-06-24T23:36:54+00:00 Referred to Ways and Means.
referral-committee - 2021-06-25T20:41:00+00:00 Recommendation: Do pass.
committee-passage-favorable - 2021-06-25T21:26:13+00:00 Second reading.
reading-2 - 2021-06-25T22:48:02+00:00 Rules suspended. Third reading. Carried by Prusak. Passed.
passage, reading-3 - 2021-06-29T19:32:41+00:00 President signed.
passage - 2021-07-01T17:35:29+00:00 Speaker signed.
passage - 2021-06-24T20:36:35+00:00 Vote explanation(s) filed by Heard.
- 2021-07-19T22:29:00+00:00 Governor signed.
executive-signature - 2021-08-20T17:05:08+00:00 Chapter 598, 2021 Laws.
- 2021-08-20T17:10:35+00:00 Effective date, January 1, 2022.
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/6e3ddba7-3757-4f3e-8247-b595adcf0a2e. Confidence: reported (aggregated from official Oregon legislature records).